SPRO logo

Spero Therapeutics (SPRO) Net Income

Annual Net Income

$22.81 M
+$69.22 M+149.13%

December 31, 2023

Summary

Performance

1-Year Change

+149.13%

3-Year Change

+129.13%

5-Year Change

+154.74%

15-Year Change

+158.86%

SPRO Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

87.58%
SPRO annual net profit is higher than 87.58% of companies in Healthcare sector

High & Low

All-time High

$22.81 M
SPRO annual net profit is currently at an all-time high

3-Year Low

-$89.76 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SPRO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
SPRO next annual earnings announcement is scheduled for Mar 13, 2025

OtherSPROprofitabilitymetrics:

Annual Net Margin

23.58%
SPRO annual net profit margin is 23.58%

Annual Revenue

$96.73 M
SPRO annual revenue is $96.73 million

Annual Gross Profit

-
SPRO annual gross profit value is unknown

Annual EPS

$0.43
SPRO annual earnings per share is $0.43

Quarterly Net Income

-$17.15 M
+$715.00 K+4.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-133.5%

3-Year Change

-133.5%

5-Year Change

-133.5%

SPRO Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.94%
SPRO quarterly net profit is higher than 28.94% of companies in Healthcare sector

High & Low

All-time High

$51.19 M
SPRO quarterly net profit is currently -133.50% below its historical high of $51.19 million

3-Year Low

-$32.83 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SPRO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SPRO next earnings announcement is scheduled for Mar 13, 2025

OtherSPROprofitabilitymetrics:

Quarterly Net Margin

-219.30%
SPRO quarterly net profit margin is -219.30%

Quarterly Revenue

$7.82 M
SPRO quarterly revenue is $7.82 million

Quarterly Gross Profit

-
SPRO quarterly gross profit value is unknown

Quarterly EPS

-$0.32
SPRO quarterly earnings per share is -$0.32

TTM Net Income

$3.51 M
-$13.94 M-79.87%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-84.6%

3-Year Change

-84.6%

5-Year Change

-84.6%

SPRO TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.47%
SPRO TTM net profit is higher than 83.47% of companies in Healthcare sector

High & Low

All-time High

$23.40 M
SPRO TTM net profit is currently -84.99% below its historical high of $23.40 million

3-Year Low

-$113.27 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SPRO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SPRO next earnings announcement is scheduled for Mar 13, 2025

OtherSPROprofitabilitymetrics:

Annual Net Margin

23.58%
SPRO annual net profit margin is 23.58%

TTM Revenue

$89.86 M
SPRO TTM revenue is $89.86 million

TTM Gross Profit

-
SPRO TTM gross profit value is unknown

TTM EPS

$0.08
SPRO TTM earnings per share is $0.08

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$22.81 M
SPRO annual net profit is $22.81 million

Annual Revenue

$96.73 M
SPRO annual revenue is $96.73 million

Annual Cost Of Goods Sold

-
SPRO annual cost of goods sold value is unknown

Annual Operating Expenses

$69.95 M
SPRO annual total operating expenses is $69.95 million

Annual Interest Expense

$0.00
SPRO annual interest expense is $0.00

Annual Income Tax

$2.60 M
SPRO annual income tax is $2.60 million

SPRO Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+149.1%-133.5%-84.6%
3 y3 years+129.1%-133.5%-84.6%
5 y5 years+154.7%-133.5%-84.6%

SPRO Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+125.4%-133.5%+47.8%-85.0%+103.1%
5 y5-yearat high+125.4%-133.5%+47.8%-85.0%+103.1%
alltimeall timeat high+125.4%-133.5%+47.8%-85.0%+103.1%

Spero Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$17.15 M(-4.0%)
$3.51 M(-79.9%)
Jun 2024
-
-$17.86 M(+41.0%)
$17.45 M(-25.4%)
Mar 2024
-
-$12.67 M(-124.7%)
$23.40 M(+2.6%)
Dec 2023
$22.81 M(-149.1%)
$51.19 M(-1697.2%)
$22.81 M(-1513.0%)
Sep 2023
-
-$3.21 M(-73.1%)
-$1.61 M(-84.0%)
Jun 2023
-
-$11.91 M(-10.2%)
-$10.08 M(-62.4%)
Mar 2023
-
-$13.27 M(-149.6%)
-$26.85 M(-42.1%)
Dec 2022
-$46.41 M(-48.3%)
$26.77 M(-329.3%)
-$46.41 M(-54.7%)
Sep 2022
-
-$11.68 M(-59.3%)
-$102.43 M(-9.6%)
Jun 2022
-
-$28.68 M(-12.6%)
-$113.27 M(+9.8%)
Mar 2022
-
-$32.83 M(+12.3%)
-$103.16 M(+14.9%)
Dec 2021
-$89.76 M(+14.7%)
-$29.24 M(+29.8%)
-$89.76 M(+13.5%)
Sep 2021
-
-$22.52 M(+21.3%)
-$79.10 M(+4.7%)
Jun 2021
-
-$18.57 M(-4.4%)
-$75.52 M(+1.4%)
Mar 2021
-
-$19.42 M(+4.5%)
-$74.44 M(-4.9%)
Dec 2020
-$78.28 M
-$18.59 M(-1.9%)
-$78.28 M(-7.6%)
Sep 2020
-
-$18.94 M(+8.2%)
-$84.68 M(+1.5%)
DateAnnualQuarterlyTTM
Jun 2020
-
-$17.50 M(-24.8%)
-$83.46 M(+5.5%)
Mar 2020
-
-$23.26 M(-6.9%)
-$79.11 M(+29.8%)
Dec 2019
-$60.92 M(+46.2%)
-$24.99 M(+41.0%)
-$60.92 M(+30.9%)
Sep 2019
-
-$17.72 M(+34.7%)
-$46.54 M(+18.5%)
Jun 2019
-
-$13.15 M(+159.3%)
-$39.28 M(+8.9%)
Mar 2019
-
-$5.07 M(-52.1%)
-$36.09 M(-13.4%)
Dec 2018
-$41.66 M(+7.5%)
-$10.60 M(+1.3%)
-$41.66 M(-7.3%)
Sep 2018
-
-$10.46 M(+5.1%)
-$44.92 M(+1.4%)
Jun 2018
-
-$9.96 M(-6.5%)
-$44.30 M(+1.8%)
Mar 2018
-
-$10.64 M(-23.2%)
-$43.51 M(+12.3%)
Dec 2017
-$38.74 M(+52.0%)
-$13.86 M(+40.9%)
-$38.74 M(+20.7%)
Sep 2017
-
-$9.84 M(+7.3%)
-$32.09 M(+12.3%)
Jun 2017
-
-$9.17 M(+56.0%)
-$28.57 M(+47.3%)
Mar 2017
-
-$5.88 M(-18.5%)
-$19.40 M(+43.4%)
Dec 2016
-$25.49 M(+151.0%)
-$7.21 M(+14.2%)
-$13.53 M(+114.2%)
Sep 2016
-
-$6.32 M
-$6.32 M
Dec 2015
-$10.15 M
-
-

FAQ

  • What is Spero Therapeutics annual net profit?
  • What is the all time high annual net income for Spero Therapeutics?
  • What is Spero Therapeutics annual net income year-on-year change?
  • What is Spero Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Spero Therapeutics?
  • What is Spero Therapeutics quarterly net income year-on-year change?
  • What is Spero Therapeutics TTM net profit?
  • What is the all time high TTM net income for Spero Therapeutics?
  • What is Spero Therapeutics TTM net income year-on-year change?

What is Spero Therapeutics annual net profit?

The current annual net income of SPRO is $22.81 M

What is the all time high annual net income for Spero Therapeutics?

Spero Therapeutics all-time high annual net profit is $22.81 M

What is Spero Therapeutics annual net income year-on-year change?

Over the past year, SPRO annual net profit has changed by +$69.22 M (+149.13%)

What is Spero Therapeutics quarterly net profit?

The current quarterly net income of SPRO is -$17.15 M

What is the all time high quarterly net income for Spero Therapeutics?

Spero Therapeutics all-time high quarterly net profit is $51.19 M

What is Spero Therapeutics quarterly net income year-on-year change?

Over the past year, SPRO quarterly net profit has changed by -$68.34 M (-133.50%)

What is Spero Therapeutics TTM net profit?

The current TTM net income of SPRO is $3.51 M

What is the all time high TTM net income for Spero Therapeutics?

Spero Therapeutics all-time high TTM net profit is $23.40 M

What is Spero Therapeutics TTM net income year-on-year change?

Over the past year, SPRO TTM net profit has changed by -$19.29 M (-84.60%)